Repligen (RGEN)

Nasdaq Health Care Biotechnology S&P MidCap 400

$173.49

+5.01 (+2.97%)

Close of Nov 06, 2026 · end-of-day data

Source: Repligen's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 02, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$104.54M	$141.24M	$194.03M	$270.25M	$366.26M	$670.53M	$801.54M	$632.36M	$634.44M	$738.26M
Cost of revenue	$47.12M	$67.05M	$86.53M	$119.10M	$156.63M	$279.28M	$345.83M	$353.92M	$359.79M	$352.01M
Gross profit	$57.42M	$74.19M	$107.50M	$151.15M	$209.63M	$391.25M	$455.71M	$278.44M	$274.64M	$386.25M
Research & development	$7.36M	$8.67M	$15.82M	$19.45M	$20.18M	$34.27M	$43.94M	$42.72M	$43.20M	$54.18M
Selling, general & admin	$30.85M	$51.51M	$65.69M	$95.61M	$119.62M	$183.87M	$215.83M	$218.58M	$263.37M	$290.51M
Operating income	$15.97M	$14.01M	$25.99M	$36.08M	$69.82M	$167.25M	$224.67M	$47.70M	-$35.11M	$55.17M
Interest expense	$3.77M	$6.44M	$6.71M	$9.29M	$10.77M	$11.28M	$1.16M	$1.95M	$20.73M	$21.51M
Pre-tax income	$11.69M	$7.25M	$21.44M	$26.15M	$59.22M	$153.54M	$219.14M	$56.71M	-$27.04M	$62.38M
Income tax	$11.00K	-$21.11M	$4.82M	$4.74M	-$709.00K	$25.25M	$33.18M	$21.11M	-$1.52M	$13.49M
Net income	$11.68M	$28.35M	$16.62M	$21.41M	$59.93M	$128.29M	$185.96M	$35.60M	-$25.51M	$48.89M
EBITDA	$21.31M	$24.51M	$41.77M	$56.95M	$96.89M	$205.70M	$275.65M	$116.26M	$34.56M	$133.91M
EPS (basic)	$0.35	$0.74	$0.38	$0.44	$1.14	$2.33	$3.35	$0.64	$-0.46	$0.87
EPS (diluted)	$0.34	$0.72	$0.37	$0.44	$1.11	$2.24	$3.24	$0.63	$-0.46	$0.86
Diluted shares	34.10K	39.15M	45.47M	49.21M	53.89K	57.26K	57.45K	56.38K	55.94K	56.56K
Gross margin	54.9%	52.5%	55.4%	55.9%	57.2%	58.3%	56.9%	44.0%	43.3%	52.3%
Operating margin	15.3%	9.9%	13.4%	13.4%	19.1%	24.9%	28.0%	7.5%	-5.5%	7.5%
Net margin	11.2%	20.1%	8.6%	7.9%	16.4%	19.1%	23.2%	5.6%	-4.0%	6.6%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$122.23M	$173.76M	$193.82M	$528.39M	$717.29M	$603.81M	$523.46M	$751.32M	$757.36M	$566.02M
Short-term investments	—	$0	$0	—	—	—	—	—	$0	$201.61M
Receivables	$15.19M	$27.59M	$33.02M	$43.07M	$71.39M	$117.42M	$116.25M	$124.16M	$134.12M	$158.59M
Inventory	$24.70M	$39.00M	$42.26M	$54.83M	$95.03M	$184.49M	$238.28M	$202.32M	$142.96M	$170.46M
Total current assets	$184.15M	$242.78M	$275.74M	$641.83M	$902.38M	$931.68M	$998.12M	$1.11B	$1.07B	$1.14B
Goodwill	$59.55M	$327.33M	$326.74M	$468.41M	$618.30M	$860.36M	$855.51M	$987.12M	$1.03B	$1.11B
Total assets	$288.91M	$743.52M	$774.62M	$1.40B	$1.90B	$2.36B	$2.53B	$2.83B	$2.83B	$2.95B
Total current liabilities	$21.07M	$25.21M	$129.84M	$48.31M	$318.96M	$375.26M	$404.20M	$164.94M	$126.79M	$135.83M
Long-term debt	—	—	—	—	—	—	—	—	$525.57M	$542.21M
Total debt	—	—	—	—	—	—	—	—	$525.57M	$542.21M
Total liabilities	$120.15M	$151.97M	$159.05M	$340.35M	$373.74M	$608.29M	$620.90M	$866.34M	$856.95M	$843.57M
Shareholders' equity	$168.76M	$591.55M	$615.57M	$1.06B	$1.53B	$1.75B	$1.91B	$1.96B	$1.97B	$2.11B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$7.52M	$17.45M	$32.77M	$67.22M	$62.62M	$119.02M	$172.08M	$113.92M	$175.39M	$117.42M
Capital expenditures	$4.33M	$5.45M	$10.63M	$18.50M	$22.45M	$67.09M	$84.83M	$36.22M	$25.68M	$23.52M
Free cash flow	$3.20M	$12.00M	$22.14M	$48.71M	$40.17M	$51.93M	$87.25M	$77.70M	$149.72M	$93.90M
Investing cash flow	-$49.19M	-$98.70M	-$14.04M	-$205.31M	-$201.38M	-$221.17M	-$233.24M	-$123.28M	-$86.38M	-$298.47M
Financing cash flow	$112.11M	$129.94M	$3.41M	$484.87M	$305.92M	$961.00K	-$13.34M	$248.96M	-$82.90M	-$15.21M
Share buybacks	—	—	—	—	—	$0	$0	$14.39M	$0	$0
Stock-based compensation	$4.59M	$6.75M	$10.19M	$12.85M	$17.01M	$27.50M	$27.32M	$25.57M	$48.07M	$32.60M
Depreciation & amortization	$5.33M	$10.51M	$15.78M	$20.87M	$27.07M	$38.45M	$50.98M	$68.56M	$69.67M	$78.75M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$166.62M	$153.18M	$158.84M	$154.87M	$167.55M	$169.17M	$182.37M	$188.81M	$197.91M	$194.25M	$204.13M	$209.31M
Cost of revenue	$88.14M	$76.39M	$77.31M	$77.38M	$128.71M	$77.80M	$89.37M	$88.29M	$96.55M	$85.97M	$94.09M	$98.33M
Gross profit	$78.48M	$76.79M	$81.53M	$77.49M	$38.84M	$91.37M	$93.00M	$100.52M	$101.36M	$108.28M	$110.04M	$110.99M
Research & development	$10.29M	$11.24M	$10.57M	$9.71M	$11.68M	$12.11M	$13.97M	$14.18M	$13.92M	$14.46M	$14.42M	$14.44M
Selling, general & admin	$57.63M	$61.80M	$65.48M	$75.61M	$60.47M	$70.71M	$70.91M	$73.66M	$75.23M	$76.54M	$76.62M	$83.59M
Operating income	$9.87M	$3.75M	$5.47M	-$7.83M	-$36.50M	$6.58M	$13.90M	$16.82M	$17.87M	$15.94M	$13.98M	-$29.55M
Interest expense	$1.14M	$4.89M	$4.98M	$5.12M	$5.46M	$5.25M	$5.35M	$5.41M	$5.50M	$5.58M	$5.66M	$5.71M
Pre-tax income	$1.86M	$3.69M	$9.03M	-$1.15M	-$38.61M	$7.94M	$18.21M	$17.11M	$19.11M	$1.77M	$14.15M	-$26.81M
Income tax	$18.32M	$399.00K	$3.31M	-$495.00K	-$4.74M	$2.11M	$3.35M	$2.20M	$5.83M	-$6.56M	$9.14M	$11.62M
Net income	-$16.45M	$3.30M	$5.71M	-$654.00K	-$33.87M	$5.83M	$14.87M	$14.91M	$13.29M	$8.33M	$5.01M	-$38.43M
EBITDA	$27.13M	$20.66M	$22.44M	$9.59M	-$18.13M	$25.28M	$33.98M	$36.83M	$37.82M	$35.70M	$33.04M	-$10.42M
EPS (basic)	$-0.29	$0.06	$0.10	$-0.01	$-0.61	$0.10	$0.26	$0.27	$0.24	$0.15	$0.09	$-0.68
EPS (diluted)	$-0.28	$0.06	$0.10	$-0.01	$-0.61	$0.10	$0.26	$0.26	$0.23	$0.15	$0.09	$-0.68
Diluted shares	-556	56.53K	56.43K	56.01K	-378	56.56M	56.51M	56.53M	-56.46M	56.67M	56.64M	56.56M
Gross margin	47.1%	50.1%	51.3%	50.0%	23.2%	54.0%	51.0%	53.2%	51.2%	55.7%	53.9%	53.0%
Operating margin	5.9%	2.4%	3.4%	-5.1%	-21.8%	3.9%	7.6%	8.9%	9.0%	8.2%	6.8%	-14.1%
Net margin	-9.9%	2.2%	3.6%	-0.4%	-20.2%	3.4%	8.2%	7.9%	6.7%	4.3%	2.5%	-18.4%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$751.32M	$780.62M	$809.15M	$783.96M	$757.36M	$697.23M	$708.86M	$748.75M	$566.02M	$582.65M	$606.78M	$726.96M
Short-term investments	—	—	—	—	$0	—	—	—	$201.61M	$201.88M	$203.67M	$136.02M
Receivables	$124.16M	$115.77M	$123.25M	$129.03M	$134.12M	$147.41M	$156.95M	$148.97M	$158.59M	$151.55M	$157.71M	$151.24M
Inventory	$202.32M	$198.03M	$190.53M	$182.47M	$142.96M	$153.11M	$155.86M	$160.32M	$170.46M	$179.26M	$186.60M	$182.21M
Total current assets	$1.11B	$1.13B	$1.16B	$1.13B	$1.07B	$1.03B	$1.06B	$1.10B	$1.14B	$1.16B	$1.20B	$1.24B
Goodwill	$987.12M	$985.96M	$985.61M	$987.62M	$1.03B	$1.08B	$1.11B	$1.11B	$1.11B	$1.11B	$1.10B	$1.10B
Total assets	$2.83B	$2.85B	$2.87B	$2.83B	$2.83B	$2.85B	$2.90B	$2.92B	$2.95B	$2.93B	$2.95B	$2.93B
Total current liabilities	$164.94M	$181.55M	$174.81M	$108.37M	$126.79M	$152.00M	$123.01M	$131.14M	$135.83M	$126.21M	$132.66M	$125.69M
Long-term debt	—	—	—	—	$525.57M	—	—	$537.93M	$542.21M	$546.59M	$551.05M	$555.60M
Total debt	—	—	—	—	$525.57M	—	—	$537.93M	$542.21M	$546.59M	$551.05M	$555.60M
Total liabilities	$866.34M	$888.10M	$881.57M	$813.96M	$856.95M	$866.66M	$839.89M	$840.62M	$843.57M	$825.31M	$838.15M	$834.67M
Shareholders' equity	$1.96B	$1.97B	$1.98B	$2.02B	$1.97B	$1.99B	$2.06B	$2.08B	$2.11B	$2.11B	$2.11B	$2.09B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$29.07M	$44.71M	$42.19M	$49.32M	$39.18M	$15.01M	$28.61M	$48.10M	$25.70M	$28.30M	$32.77M	$43.10M
Capital expenditures	$11.09M	$8.35M	$4.81M	$6.98M	$5.54M	$3.56M	$7.10M	$4.70M	$8.15M	$4.71M	$5.33M	$4.95M
Free cash flow	$17.98M	$36.36M	$37.38M	$42.34M	$33.64M	$11.44M	$21.51M	$43.40M	$17.55M	$23.59M	$27.43M	$38.15M
Investing cash flow	-$169.91M	-$8.36M	-$7.40M	-$5.86M	-$64.76M	-$74.11M	-$7.84M	-$7.78M	-$208.74M	-$3.99M	-$2.09M	$63.99M
Financing cash flow	$268.13M	-$8.97M	-$5.77M	-$69.60M	$1.45M	-$5.03M	-$10.13M	-$239.00K	$195.00K	-$5.54M	-$6.20M	$14.60M
Stock-based compensation	$6.46M	$8.78M	$9.88M	$23.05M	$6.36M	$7.27M	$8.38M	$8.97M	$7.98M	$8.32M	$8.01M	$9.36M
Depreciation & amortization	$17.26M	$16.91M	$16.98M	$17.42M	$18.37M	$18.70M	$20.08M	$20.01M	$19.95M	$19.76M	$19.06M	$19.12M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.